#CCR5

In an ongoing trial of people on failing antiretroviral regimens, the injectable PRO 140 reduced viral load considerably.

Researchers will genetically engineer participants’ CD4 cells, disabling the attachment of the virus.

Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.

So why is he taking meds every day?

Investigators have created a consortium hoping to yield HIV cures through stem cell transplants like the ones that cured the Berlin Patient.

Cutting through the hype and hyperbole.

The U.S. Food and Drug Administration (FDA) has given the green light to an early human trial of an HIV gene therapy for a functional cure.

The drug Cytoxan is safe and relatively well tolerated and augments the uptake of immune cells genetically engineered to resist HIV.

Scientists have proved that it is possible to engineer immune cells to control HIV without ongoing antiretroviral therapy.

A study of a genetic therapy has reduced the size of the HIV reservoir in seven of nine study subjects and has also led to long-term CD4 incre...

Scientists have proved that it is possible to engineer immune cells to control HIV for a sustained period of time without the need for ongoing...

He had a malfunctioning CCR5 receptor on his CD4 cells.

For the first time, researchers have documented the microscopic structure of the CCR5 coreceptor, which HIV binds to in order to begin its ent...

How pharmaceutical and biotech companies are playing a major role in the search for an HIV cure.

Two new gene therapy studies further the hopes that scientists may develop widely replicable methods to control HIV through stem cell modifica...

The HIV antiretroviral Selzentry (maraviroc) combats the potentially lethal pathogen Staphylococcus aureus.